XT
JSPR icon

XTX Topco’s Jasper Therapeutics JSPR Stock Holding History

XTX Topco’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.5K Buy
+39,431
New +$54.7K ﹤0.01% 3417
2025
Q3 		– Sell
-27,348
Closed -$152K – 2911
2025
Q2 		$152K Buy
+27,348
New +$135K 0.01% 1786
2023
Q3 		– Sell
-1,129
Closed -$15.5K – 1785
2023
Q2 		$15.5K Buy
+1,129
New +$16.8K ﹤0.01% 1329

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

XTX Topco's JSPR Position: Q1 2026 in Review

XTX Topco opened a new position in Jasper Therapeutics (JSPR) in Q1 2026: 39,431 shares worth $34.5K. The stake represents ﹤0.01% of the portfolio and ranks #3417 among its holdings. This is a return to the name: XTX Topco previously reported a position in JSPR as recently as Q2 2025.

XTX Topco first reported a position in JSPR in Q2 2023 and has held it in 3 quarters since. The position peaked at $152K in Q2 2025. 58 funds tracked by Wall St. Rank hold JSPR as of Q1 2026.

  • XTX Topco held 39,431 shares of Jasper Therapeutics worth $34.5K as of Q1 2026.
  • Jasper Therapeutics was a new XTX Topco position in Q1 2026.
  • Jasper Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3417 holding.
  • XTX Topco first reported a position in Jasper Therapeutics in Q2 2023 and has held it in 3 quarters since.
  • XTX Topco's Jasper Therapeutics position peaked at $152K in Q2 2025.
  • 58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.